Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Bo G. Winkel"'
Autor:
Christian Paludan‐Müller, Niels K. Stampe, Laia M. Monfort, Laura Andreasen, Oliver B. Vad, Gustav Ahlberg, Jens B. Johansen, Bo G. Winkel, Christian Torp‐Pedersen, Lars Køber, Emil L. Fosbøl, Jesper H. Svendsen, Morten S. Olesen
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 9 (2024)
Externí odkaz:
https://doaj.org/article/0e9f9ac9c57b43fd850bec40043ea05b
Autor:
Camilla H. B. Jespersen, Johanna Krøll, Priya Bhardwaj, Carl Johann Hansen, Jesper Svane, Bo G. Winkel, Christian Jøns, Peter Karl Jacobsen, Jens Haarbo, Jens Cosedis Nielsen, Jens Brock Johansen, Berit T. Philbert, Sam Riahi, Christian Torp‐Pedersen, Lars Køber, Jacob Tfelt‐Hansen, Peter E. Weeke
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 7 (2023)
Background Patients with Brugada syndrome (BrS) are recommended to avoid drugs that may increase their risk of arrhythmic events. We examined treatment with such drugs in patients with BrS after their diagnosis. Methods and Results All Danish patient
Externí odkaz:
https://doaj.org/article/f0aa4ea3d9cc40a5b070cda0eb5ee8be
Autor:
Anders G. Holst, Kirstine Calloe, Thomas Jespersen, Pernille Cedergreen, Bo G. Winkel, Henrik Kjaerulf Jensen, Trond P. Leren, Stig Haunso, Jesper Hastrup Svendsen, Jacob Tfelt-Hansen
Publikováno v:
Case Reports in Medicine, Vol 2009 (2009)
Brugada syndrome (BrS) is a primary electrical heart disease, which can lead to sudden cardiac death. In older patients with BrS, the disease may coexist with ischaemic heart disease (IHD) and recent studies support a synergistic proarrhythmic effect
Externí odkaz:
https://doaj.org/article/9586ef012b914426a9670578677b1551
Autor:
Johanna Krøll, Jawad H Butt, Henrik K Jensen, Emil L Fosbøl, H B Jespersen Camilla, Bo G Winkel, Jørgen K Kanters, Gunnar H Gislason, Christian Torp-Pedersen, Lars Køber, Henning Bundgaard, Jacob Tfelt-Hansen, Peter E Weeke
Publikováno v:
Krøll, J, Butt, J H, Jensen, H K, Fosbøl, E L, Jespersen, C, Winkel, B G, Kanters, J K, Gislason, G H, Torp-Pedersen, C, Køber, L, Bundgaard, H, Tfelt-Hansen, J & Weeke, P E 2023, ' β-blocker adherence among patients with congenital Long QT Syndrome : a nationwide study ', European heart journal. Quality of care & clinical outcomes, vol. 9, no. 1, pp. 76-84 . https://doi.org/10.1093/ehjqcco/qcac017
Krøll, J, Butt, J H, Jensen, H K, Fosbøl, E L, Jespersen, C, Winkel, B G, Kanters, J K, Gislason, G H, Torp-Pedersen, C, Køber, L, Bundgaard, H, Tfelt-Hansen, J & Weeke, P E 2023, ' β-blocker adherence among patients with congenital Long QT Syndrome : a nationwide study ', European heart journal. Quality of care & clinical outcomes, vol. 9, no. 1, pp. 76–84 . https://doi.org/10.1093/ehjqcco/qcac017
Krøll, J, Butt, J H, Jensen, H K, Fosbøl, E L, Jespersen, C, Winkel, B G, Kanters, J K, Gislason, G H, Torp-Pedersen, C, Køber, L, Bundgaard, H, Tfelt-Hansen, J & Weeke, P E 2023, ' β-blocker adherence among patients with congenital Long QT Syndrome : a nationwide study ', European heart journal. Quality of care & clinical outcomes, vol. 9, no. 1, pp. 76–84 . https://doi.org/10.1093/ehjqcco/qcac017
Aim β-blockers are the first line of treatment in patients with congenital long QT syndrome (cLQTS) (class I or II recommendation) in order to prevent malignant arrhythmias. Hence, we examined long-term β-blocker adherence and associated risk facto
Autor:
Johan D V, Jokinen, Christian J, Carlsson, Søren M, Rasmussen, Olav W, Nielsen, Bo G, Winkel, Lars N, Jorgensen, Michael P, Achiam, Jesper, Mølgaard, Helge B D, Sørensen, Eske K, Aasvang, Christian S, Meyhoff
Publikováno v:
Anesthesia and analgesia. 135(1)
New-onset postoperative atrial fibrillation (POAF) is associated with several cardiovascular complications and higher mortality. Several pathophysiological processes such as hypoxia can trigger POAF, but these are sparsely elucidated, and POAF is oft
Autor:
Cathrine V. Dalgaard, Benjamin L. Hansen, Elisabeth M. Jacobsen, Amalie Kjerrumgaard, Jacob Tfelt‐Hansen, Peter E. Weeke, Bo G. Winkel, Alex H. Christensen, Henning Bundgaard
Publikováno v:
Dalgaard, C V, Hansen, BL, Jacobsen, EM, Kjerrumgaard, A, Tfelt-Hansen, J, Weeke, P E, Winkel, BG, Christensen, A H & Bundgaard, H 2022, ' Sudden unexplained death versus nonautopsied possible sudden cardiac death : Findings in relatives ', Journal of Cardiovascular Electrophysiology, vol. 33, no. 2, pp. 254-261 . https://doi.org/10.1111/jce.15333
Background: International guidelines recommend work-up of relatives to autopsy negative sudden cardiac death victims, denoted as sudden unexplained death (SUD) and nonautopsied possible sudden cardiac death (pSCD) victims. This study assesses and com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98ebbe5ab5918e44360ff0be9b71e87e
https://curis.ku.dk/ws/files/291666534/AASA_Cardiovasc_electrophysiol_2021_Dalgaard_Sudden_unexplained_death_vs_non_autopsied_possible_sudden_cardiac_death_1_.pdf
https://curis.ku.dk/ws/files/291666534/AASA_Cardiovasc_electrophysiol_2021_Dalgaard_Sudden_unexplained_death_vs_non_autopsied_possible_sudden_cardiac_death_1_.pdf
Autor:
Anders Gaarsdal, Holst, Jacob, Tfelt-Hansen, Morten S, Olesen, Juliane, Theilade, Bo G, Winkel, Alex H, Christensen, Henning, Bundgaard, Stig, Haunsø, Jesper Hastrup, Svendsen
Publikováno v:
Ugeskrift for laeger. 172(31)
Catecholaminergic polymorphic ventricular tachycardia is a rare inherited heart disease, which can lead to life-threatening ventricular arrhythmias in patients with a structurally normal heart. The age of onset is usually between two and 12 years and